Statistics

Total Visits

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants92

Select a period of time:

Number of views in the range

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants32

Views

Views
May 20251
June 20254
July 202516
August 20252
September 20254
October 20253
November 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Brazil8
United Kingdom4
Argentina1
Ecuador1
Mexico1
South Africa1
 

Top cities views

Views
Brasília1
Camaçari1
Chicago1
Columbus1
Conyers1
Dallas1
Erie1
Johannesburg1
Lancaster1
Mendoza1